Artificial Cells, Nanomedicine, and Biotechnology
Overview
'Artificial Cells, Nanomedicine, and Biotechnology' is a multidisciplinary journal that focuses on the cutting-edge research and advancements in the fields of artificial cells, nanomedicine, and biotechnology. It covers a wide range of topics including the design and synthesis of artificial cells, nanotechnology-based drug delivery systems, tissue engineering, regenerative medicine, and the application of biotechnology in healthcare. The journal provides a platform for scientists, researchers, and practitioners to share their innovative findings and contribute to the development of these rapid
Details
Details
Abbr.
Artif Cells Nanomed Biotechnol
Start
2013
End
Continuing
Frequency
Bimonthly
p-ISSN
2169-1401
e-ISSN
2169-141X
Country
United Kingdom
Language
English
Specialties
Biomedical Engineering
Biotechnology
Biotechnology
Metrics
Metrics
h-index / Ranks: 3937
86
SJR / Ranks: 6962
646
CiteScore / Ranks: 548
15.90
JIF / Ranks: 1190
5.8
Recent Articles
1.
2.
Jagielski J, Dydak K, Jaskot K, Soloviov D, Kozak M, Nowaczyk G
Artif Cells Nanomed Biotechnol
. 2025 Mar;
53(1):69-86.
PMID: 40066979
The rise of antibiotic-resistant bacteria demands new antimicrobial strategies. Glyceryl monolaurate (GML) shows antibacterial activity against Gram-positive bacteria like but is ineffective against Gram-negative due to its outer membrane. GML's...
3.
Clerici M, Ciardulli M, Lamparelli E, Lovecchio J, Giordano E, Dale T, et al.
Artif Cells Nanomed Biotechnol
. 2025 Mar;
53(1):1-16.
PMID: 40063517
Tendon injuries significantly impact quality of life, prompting the exploration of innovative solutions beyond conventional surgery. Extracellular Vesicles (EVs) have emerged as a promising strategy to enhance tendon regeneration. In...
4.
Budgude P, Kale V, Vaidya A
Artif Cells Nanomed Biotechnol
. 2025 Mar;
53(1):122-137.
PMID: 40062630
The signaling mechanisms active within mesenchymal stromal cells (MSCs) influence the composition of microvesicles (MVs) and exosomes (Exos) secreted by them. Previously, we showed that priming MSCs with a p38...
5.
Wang Y, Peng X, Qian B, Wang L, Wang J
Artif Cells Nanomed Biotechnol
. 2025 Mar;
53(1):105-121.
PMID: 40055878
This study integrates metabolites from Forsythia suspensa (FS) and gut microbiota GM to assess combined therapeutic efficacy against drug-induced liver injury (DILI) using network pharmacology and molecular docking. Metabolites of...
6.
7.
8.
Huang J, Wang L, Zhou J, Dai T, Zhu W, Wang T, et al.
Artif Cells Nanomed Biotechnol
. 2025 Mar;
53(1):57-68.
PMID: 40022676
Ageing significantly contributes to osteoarthritis (OA) and metabolic syndrome (MetS) pathogenesis, yet the underlying mechanisms remain unknown. This study aimed to identify ageing-related biomarkers in OA patients with MetS. OA...
9.
Udappusamy V, Thinagaran R, Mayakrishnan V, Balakarthikeyan J, Kannappan P, Al-Ghamdi S, et al.
Artif Cells Nanomed Biotechnol
. 2025 Feb;
53(1):43-55.
PMID: 39927587
Triple-negative breast cancer (TNBC) is a significant global health issue, with high mortality rates. The chemotherapeutic drugs currently used for TNBC have significant side effects, impacting both normal and cancer...
10.
Salsabila S, Khairinisa M, Wathoni N, Sufiawati I, Mohd Fuad W, Khairul Ikram N, et al.
Artif Cells Nanomed Biotechnol
. 2025 Feb;
53(1):1-15.
PMID: 39924869
Chitosan nanoparticles have been extensively utilised as polymeric drug carriers in nanoparticles formulations due to their potential to enhance drug delivery, efficacy, and safety. Numerous toxicity studies have been previously...